Comparative Investigation of Amino Acids Content in the Dry Extracts of <i>Juno bucharica</i>, <i>Gladiolus Hybrid Zefir</i>, <i>Iris Hungarica,</i> <i>Iris Variegata</i> and <i>Crocus Sativus</i> Raw Materials of Ukrainian Flora
The aim of this research was the comparative study of the amino acids content in the dry extracts of <i>Iridaceae</i> plants of Ukrainian flora: <i>Juno bucharica</i> leaves and corms, <i>Gladiolus hybrid Zefir</i> leaves, <i>Iris hungarica</i> and <...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The aim of this research was the comparative study of the amino acids content in the dry extracts of <i>Iridaceae</i> plants of Ukrainian flora: <i>Juno bucharica</i> leaves and corms, <i>Gladiolus hybrid Zefir</i> leaves, <i>Iris hungarica</i> and <i>Iris variegata</i> rhizomes, and <i>Crocus sativus</i> stigmas, flowers, leaves and corms. A gas chromatography−mass spectrometry (GC−MS) method has been used. Separation of amino acids in the samples was carried out using a Shimadzu GC-MS-QP2010 equipped with an Rxi-5ms (Restek Corporation capillary column (30 m long, 0.25 mm outer diameter and 0.25 µm) with a liquid stationary phase (5% diphenyl and 95% polysiloxane) after derivatization with N-(t-butyldimethylsilyl)-N109 methyltrifluoroacetamide (MTBSTFA) reagent. The results obtained have shown that extracts from the aerial parts of plants investigated have a higher amino acid content and more diverse composition than the underground organs. Experimental data showed that <i>Crocus</i> leaves and <i>Juno</i> leaves extracts contain the highest general content of amino acids—31.99 mg/g and 14.65 mg/g respectively. All samples showed a high content of L-pyroglutamic acid (0.33−12.35 mg/g). Moreover, <i>Crocus</i> leaves and <i>Juno</i> leaves extracts had the most suitable amino acids composition and are prospective for further pharmacological studies. |
---|---|
Item Description: | 2218-0532 10.3390/scipharm88010008 |